Table 1.
Hepatic and splenic Ki/V(0), glucose uptake rates (MRglu), SUVmax and b/A in groups 1 to 4 (n = 59)
| Group (n) | Ki/V(0) | MRglu | SUVmax | b/A | |||
|---|---|---|---|---|---|---|---|
|
| |||||||
| ml/min/100 ml | μmol/min/100 ml | %/min | |||||
|
| |||||||
| Liver | Spleen | Liver | Spleen | Liver | Spleen | ||
| 1. (13) | 0.37 (0.20) | 1.01 (0.59)* | 2.4 (1.6) | 6.4 (4.2)* | 3.3 (0.7) | 2.7 (0.8)¶ | -0.52 (0.55)* |
| 2. (8) | 0.32 (0.23) | 0.49 (0.23) | 1.6 (1.3) | 2.7 (1.3) | 3.4 (1.0) | 2.3 (0.6) | -0.15 (0.15) |
| 3. (25) | 0.42 (0.21) | 0.52 (0.26) | 2.5 (1.3) | 3.1 (1.8) | 3.2 (0.7) | 2.3 (0.5) | -0.12 (0.23) |
| 4. (13) | 0.33 (0.20) | 0.50 (0.30) | 2.0 (1.4) | 3.0 (2.0) | 3.1 (0.6) | 2.3 (0.5) | -0.22 (0.34) |
Group 1 significantly higher compared with groups 2-4 combined
P<0.001;
P = 0.03.
Group 1: active LPD (abnormal PET/CT); group 2: inactive LPD (normal PET/CT); group 3: abnormal PET/CT (not LPD); group 4: normal PET/CT (no history of LPD).